Yoshimura, Shinichi
Uchida, Kazutaka
Sakai, Nobuyuki
Imamura, Hirotoshi
Yamagami, Hiroshi
Tanaka, Kanta
Ezura, Masayuki
Nonaka, Tadashi
Matsumoto, Yasushi
Shibata, Masunari
Ohta, Hajime
Morimoto, Masafumi
Fukawa, Norihito
Hatano, Taketo
Enomoto, Yukiko
Takeuchi, Masataka
Ota, Takahiro
Shimizu, Fuminori
Kimura, Naoto
Kamiya, Yuki
Shimamura, Norito
Morimoto, Takeshi http://orcid.org/0000-0002-6844-739X
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 19 May 2020
Revised: 29 July 2020
Accepted: 31 July 2020
First Online: 7 August 2020
Change Date: 22 October 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12975-020-00871-4
Compliance with Ethical Standards
:
: Dr. Yoshimura discloses research grants from Bristol-Myers Squibb and lecturer’s fees from Boehringer Ingelheim, Daiichi Sankyo, Bayer, Pfizer, and Bristol-Myers Squibb. Dr. Uchida reports lecturer’s fees from Daiichi Sankyo. Dr. Sakai reports a research grant from Daiichi Sankyo. Dr. Yamagami discloses research grants from Bristol-Myers Squibb; lecturer’s fees from Bayer, Daiichi Sankyo, Bristol-Myers Squibb, and Boehringer Ingelheim; and membership of the advisory boards for Daiichi Sankyo. Dr. Tanaka reports a lecturer’s fee from Daiichi Sankyo. Dr. Ezura reports lecturer’s fees from Boehringer Ingelheim and Pfizer. Dr. Shibata reports lecturer’s fees from Daiichi Sankyo. Dr. Takeuchi reports lecturer’s fees from Daiichi Sankyo. Dr. T Morimoto reports lecturer’s fees from Daiichi Sankyo and Pfizer, a manuscript fee from Pfizer, and membership of the advisory boards for Bristol-Myers Squibb. Dr. Kamiya discloses research grants from Bristol-Myers Squibb and lecturer’s fees from Daiichi Sankyo. Dr. Imamura, Dr. Nonaka, Dr. Matsumoto, Dr. Ohta, Dr. M Morimoto, Dr. Fukawa, Dr. Hatano, Dr. Enomoto, Dr. Ota, Dr. Shimizu, Dr. Kimura, and Dr. Shimamura have no disclosures to report.
: The institutional review boards of all 38 participating centers approved the study protocol.
: A written informed consent was obtained from the prospectively registered patients and from an opt-out method from the retrospectively registered patients. This method was approved by the institutional review boards in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan.
: Consent for publication was expressed in the written informed consent and opt-out method.